Toward understanding the pathogenic mechanisms in gelsolin-related amyloidosis: In vitro expression reveals an abnormal gelsolin fragment

Human Molecular Genetics

Volumn 3, Issue 12, 1994, Pages 2223-2229

  Paunlo, Tllna ^a   Kangas, Hannele ^a   Kalkklnen, Nisse ^a,b   Haltia, Matti ^a,c   Palo, Jorma ^a,c   Peltonen, Leena ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; AMYLOID; ASPARAGINE; ASPARTIC ACID; COMPLEMENTARY DNA; GELSOLIN; METALLOPROTEINASE; NUCLEOTIDE; PROTEIN; TYROSINE;

AMINO ACID SUBSTITUTION; AMYLOIDOSIS; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CARBOXY TERMINAL SEQUENCE; CELL STRAIN COS1; CORNEA; DNA SEQUENCE; DYSTROPHY; FAMILIAL DISEASE; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MESENCHYME; NUCLEOTIDE SEQUENCE; POLYNEUROPATHY; PRIORITY JOURNAL; PROTEIN DEGRADATION;

AMYLOID NEUROPATHIES; ANIMAL; BASE SEQUENCE; CERCOPITHECUS AETHIOPS; CHROMOSOMES, HUMAN, PAIR 9; DNA, COMPLEMENTARY; GELSOLIN; GENE EXPRESSION; HUMAN; MOLECULAR SEQUENCE DATA; POINT MUTATION; SUPPORT, NON-U.S. GOV'T; TRANSFECTION;

EID: 0028567731     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/3.12.2223     Document Type: Article

References (38)

1. Meretqja, J. (1973) Genetic aspects of familial amyloidosis with comeal lattice dystrophy and cranial neuropathy. Clin. Gena., 4, 173-185.
2. Meretoja J. (1969) Familial systemic paramyloidosis with lattice dystrophy of the cornea, progressive cranial neuropathy, skin changes and various intentai symptoms. A previously unrecognized heritable syndrome. Ann. Qin. Res., 1, 314-324.
3. Kiuru, S. and Seppäl Sinen, A.M. (1994) Neuropathy in familial amyloidosis, Furnish type (FAF): electrophysiological studies. Muscle Nerve, 17, 299-304.
4. Glenner G.G. (1980) Amyloid deposits and amyloidosis: the 0-fibrilloses. N. Engl. J. Med., 302, 1283-1292, 1333-1343.
5. Maury, C.P., Alli J.C. and Baumann, M. (1990) Furnish hereditary amyloidosis. Amino acid sequence homology between the amyloid fibril protein and human plasma gelsoline. FEES Lett., 260, 85-87.
6. Natvig J.B., Forre O. and Husby, G. (eds) (1990)Amyloid Amyloidosis, Vol. 1. Kluwer Academic Publishers, Dordrecht.
7. Kwiatkowski, D.J., Mehl R., Izumo S., Nadal-Ginard, B. and Yin H.L. (1988) Muscle is the major source of plasma gelsolin. J. Biol. Chem., 263, 8239-8243.
8. Kwiatkowski, D.J., Westbrook, C.A., Bruns, G.A.P. and Morton, C.C. (1988) Localization of gelsolin proximal to ABL on chromosome 9. Am. J. Hum. Genet., 42, 565-572.
9. Kwiatkowski, D.J., Mehl R. and Yin H.L. (1988) Genomic organization and biosynthesis of secreted and cytoplasmic forms of gelsolin. J. Cell Biol., 106, 375-384.
10. Kwiatkowski, D.J., Stossd T.P., Orkin S.H., Mole J.E., Colten H.R. and Yin H.L. (1986) Plasma and cytoplasmic gelsolins are encoded by a single gene and contain a duplicated actin-binding domain. Nature, 323, 455-458.
11. Levy E., Haltia M., Femandez-Madrid, I., Koivunen O., Ghiso J., Prelli F. and Frangione B. (1990) Mutation in gelsolin gene in Finnish hereditary amyloidosis. J. Exp. Med., 172, 1865-1867.
12. Maury, C.P., Kere J., Tolvanen R. and de la Chapelle, A. (1990) Finnish hereditary amyloidosis is caused by a single nucleotide substitution in the gelsolin gene. FEBS Lett., 276, 75-77.
13. w-A) mutation of gelsolin in all affected individuals with Finnish type of familial amyloidosis. Genomics, 13, 237-239.
14. Sunada Y., Shimizu, T., Nakase H., Ohta S., Asaoka T., Amano S., Sawa, M., Kagawa Y., Kanazawa, I. and Mannen, T. (1993) Inherited amyloid polyneuropathy type IV (gelsolin variant) in a Japanese family. Ann. Neurol., 33, 57-62.
15. Gorevic P.D., Munoz, P.C., Gorgone, G., Purcell JJ., Jr., Rodrigues, M., Ghiso J., Levy E., Haltia M. and Frangione B. (1991) Amyloidosis due to a mutation of the gelsolin gene in an American family with lattice corneal dystrophy type n. N. Engl. J. Med., 325, 1780-1785.
16. Cliapelle, A., Kere J., Sack, G.H. Jr., Tolvanen R. and Maury, C.P. (1992) Familial amyloidosis, Finnish type: G654-A mutation of the gelsolin gene in Finnish families and an unrelated American family. Genomics, 13, 898-901.
17. De la Chapelle, A., Tolvanen R., Boysen G., Santavy J., Bleeker-Wagemakers L., Maury, C.P. and Kere J. (1992) Gelsolin-derived familial amyloidosis caused by asparagine or tyrosine substitution for aspartic acid at residue 187. Nature Genet., 2, 157-160.
18. Hiltunen T., Kiunt S., Hongell V., Helio T., Palo J. and Peltonen L. (1991) Finnish type of familial amyloidosis: cosegregation of Asp, Asn mutation of gelsolin with the disease in three latge families. Am. J. Hum. Genet., 49, 522-528.
19. Maury, C.P., Nurmiaho-Lassila E.L. and Rossi, H. (1994) Amyloid fibril formation in gelsolin-derived amyloidosis. Definition of the amyloidogenic region and evidence of accelerated amyloid formation of mutant Asn-187 and Tyr-187 gelsolin peptides. Lab. Invest., 70, 558-564.
20. McLaughlin, P.J., Gooch J.T., Mannherz H.G. and Weedi A.G. (1993) Structure of gelsolin segment 1-acdn complex and the mechanism of filament severing. Nature, 364, 685-692.
21. Maury, C.P. and Rossi, H. (1993) Demonstration of a circulating 65K gelsolin variant specific for familial amyloidosis, Finnish type. Biochem. Biophys. Res. Commun., 191, 41-44.
22. Sunada Y., Sakurai T., Nonomura Y. and Kanazawa, I. (1994) In Kisilevsky.R., Benson, M.D., Frangione.B., GauldieJ., Muckle.TJ. and Young, I. D. (eds), Amyloid and Amyloidosis.Parthenon Publishing, London, pp. 623-625.
23. Paunio T., Kiuru S., Karonen S.L., Palo J. and Peltonen L. (1994) Quantification of serum and cerebrospinal fluid gelsolin in familial amyloidosis, Finnish type (AGel). Amyloid. Int. J. Exp. Clin. Invest., 1, 80-89.
24. Ikonen E., Enomaa N., Ulmanen I. and Peltonen L. (1991)In vitro mutagenesis helps to unravel the biological consequences of aspartylglucosaminuria mutation. Genomics, 11, 206-211.
25. Saraste J. and Kuismanen E. (1984) Pre- and post-Golgi vacuoles operate in the transport of Semliki Forest virus membrane glycoproteins to the cell surface. Cell, 38, 535-549.
26. Beynon R.J. and Salvesen G. (1990) In Beynon RJ. and Bond J.S. (eds), Proteolytic Enzymes. A Practical Approach.IRL Press, Oxford, pp. 241-249.
27. Meretqja J. and Lyly T. (1971) Histopathological findings of familial amyloidosis with cranial neuropathy as principal manifestation. Acta Pathol. Microbiol. Scand. Section A, 79, 432-440.
28. Boysen G., Galassi G., Kamieniecka Z., Schlaeger J. and Trojaborg W. (1979) Familial amyloidosis with cranial neuropathy and comeal lattice dystrophy. J. Neurol. Neurosurg. Psychiatry, 42, 1020-1030.
29. Citron, M., Oltersdorf T., Haass C., McConlogue L., Hung, A.Y., Seubert P., Vigo-Pdfiey, C., Lieberburg J. and Selkoe DJ. (1992) Mutation of the beta-amyloid precursor protein in familial Alzheimer’s disease increases beta-protein production. Nature, 360, 672-674.
30. Cai X.D., Golde T.E. and Younkin S.G. (1993) Release of excess amyloid beta protein from a mutant amyloid beta protein precursor. Science, 259, 514-516.
31. Suzuki, N., Cheung, T.T., Cai X.D., Odaka A., Otvos L. Jr., Eckman C., Golde T.E. and Younkin S.G. (1994) An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. Science, 264, 1336-1340.
32. Taylor J.W., Ott J. and Eckstein F. (1985) The rapid generation of oligonucleotide-directed mutations at high frequency using phosphorothioate-modified DNA. Nucleic Adds Res., 13, 8764-8765.
33. Sanger, F., Nicklen S. and Coulson A.R. (1977) DNA sequencing with chainterminating inhibitors. Proc. Natl Acad. Sd. USA, 74, 5463-5467.
34. Okayama, H. and Berg P. (1983) A cDNA cloning vector that permits expression of cDNA inserts in mammalian cells. Mol. CeU. Biol., 3, 280-289.
35. Luthman H. and Magnusson G. (1983) High efficiency polyoma DNA tranffection of chloroquine treated cells. Nucleic Adds Res., 11, 1295-1307.
36. Feigner, P.L., Gadek T.R., Holm M., Roman, R., Chan H.W., Wenz M., Northrop J.P., Ringokl G.M. and Danielsen, M. (1987) Lipofectioo: A highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl Acad. Sd. USA, 84, 7413-7417.
37. Chapotmier C., Janmey P.A. and Yin H.L. (1986) The actin filamett-severing domain of plasma gelsolin. J. Cell Biol., 103, 1475-1481.
38. Haltia M., Prelli F., Ghiso J., Kiuru S., Somer J.L., Palo J. and Frangione B. (1990) Amyloid protein in familial amyloidosis (Finnish type) is homologous to gelsolin, an actin-binding protein. Biochem. Biophys. Res. Commun., 167, 927-932.